|
1
|
Cooper ME: Pathogenesis, prevention, and
treatment of diabetic nephropathy. Lancet. 352:213–219. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanwar YS, Sun L, Xie P, Liu FY and Chen
S: A glimpse of various pathogenetic mechanisms of diabetic
nephropathy. Annu Rev Pathol. 6:395–423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eddy AA: Molecular basis of renal
fibrosis. Pediatr Nephrol. 15:290–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu N, Duan J, Li H, Wang Y, Wang F, Chu J,
Sun J, Liu M, Wang C, Lu C and Wen A: Hydroxysafflor yellow a
ameliorates renal fibrosis by suppressing TGF-β1-induced
epithelial-to-mesenchymal transition. PLoS One. 11:e01534092016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burns WC and Thomas MC: Angiotensin II and
its role in tubular epithelial to mesenchymal transition associated
with chronic kidney disease. Cells Tissues Organs. 193:74–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang YL, Ju HZ, Liu SF, Lee TC, Shih YW,
Chuang LY, Guh JY, Yang YY, Liao TN, Hung TJ and Hung MY: BMP-2
suppresses renal interstitial fibrosis by regulating epithelial
mesenchymal transition. J Cell Biochem. 112:2558–2565. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: Pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rösen P, Nawroth PP, King G, Möller W,
Tritschler HJ and Packer L: The role of oxidative stress in the
onset and progression of diabetes and its complications: A summary
of a congress series sponsored by UNESCO-MCBN, the American
diabetes association and the German diabetes society. Diabetes
Metab Res Rev. 17:189–212. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kashihara N, Haruna Y, Kondeti VK and
Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem.
17:4256–4269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brownlee M: The pathobiology of diabetic
complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith KA, Zhou B, Avdulov S, Benyumov A,
Peterson M, Liu Y, Okon A, Hergert P, Braziunas J, Wagner CR, et
al: Transforming growth factor-β1 induced epithelial mesenchymal
transition is blocked by a chemical antagonist of translation
factor eIF4E. Sci Rep. 5:182332015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shirakihara T, Horiguchi K, Miyazawa K,
Ehata S, Shibata T, Morita I, Miyazono K and Saitoh M: TGF-β
regulates isoform switching of FGF receptors and
epithelial-mesenchymal transition. EMBO J. 30:783–795. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hills CE and Squires PE: The role of TGF-β
and epithelial-to mesenchymal transition in diabetic nephropathy.
Cytokine Growth Factor Rev. 22:131–139. 2011.PubMed/NCBI
|
|
16
|
Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y,
Wang T, Xia YF, Dai Y and Wei ZF: Paeoniflorin suppresses TGF-β
mediated epithelial-mesenchymal transition in pulmonary fibrosis
through a Smad-dependent pathway. Acta Pharmacol Sin. 37:794–804.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kattla JJ, Carew RW, Heljic M, Godson C
and Brazil DP: Protein kinase B/Akt activity is involved in renal
TGF-beta1-driven epithelial-mesenchymal transition in vitro and in
vivo. Am J Physiol Renal Physiol. 295:F215–F225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Risso G, Blaustein M, Pozzi B, Mammi P and
Srebrow A: Akt/PKB: One kinase, many modifications. Biochem J.
468:203–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Q, Zhai Y, Cheng Q, Liu Y, Gao X, Zhang
T, Wei Y, Zhang F and Yin X: The Akt-FoxO3a-manganese superoxide
dismutase pathway is involved in the regulation of oxidative stress
in diabetic nephropathy. Exp Physiol. 98:934–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Q, Zuo WZ, Ji XJ, Zhou YX, Liu YQ, Yao
XQ, Zhou XY, Liu YW, Zhang F and Yin XX: Ethanolic Ginkgo biloba
leaf extract prevents renal fibrosis through Akt/mTOR signaling in
diabetic nephropathy. Phytomedicine. 22:1071–1078. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai X and Jiang Y: Key factors in mTOR
regulation. Cell Mol Life Sci. 67:239–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma XM and Blenis J: Molecular mechanisms
of mTOR-mediated translational control. Nat Rev Mol Cell Biol.
10:307–318. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inoki K: Role of TSC-mTOR pathway in
diabetic nephropathy. Diabetes Res Clin Pract. 82 Suppl 1:S59–S62.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin CJ, Chen TL, Tseng YY, Wu GJ, Hsieh
MH, Lin YW and Chen RW: Honokiol induces autophagic cell death in
malignant glioma through reactive oxygen species-mediated
regulation of the p53/PI3K/Akt/mTOR signaling pathway. Toxicol Appl
Pharmacol. 304:59–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yalcin S, Marinkovic D, Mungamuri SK,
Zhang X, Tong W, Sellers R and Ghaffari S: ROS-mediated
amplification of AKT/mTOR signalling pathway leads to
myeloproliferative syndrome in Foxo3(−/-) mice. EMBO J.
29:4118–4131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fantus D, Rogers NM, Grahammer F, Huber TB
and Thomson AW: Roles of mTOR complexes in the kidney: Implications
for renal disease and transplantation. Nat Rev Nephrol. 12:587–609.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lieberthal W and Levine JS: The role of
the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc
Nephrol. 20:2493–2502. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lamouille S and Derynck R: Emergence of
the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin
axis in transforming growth factor-β-induced epithelial-mesenchymal
transition. Cells Tissues Organs. 193:8–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu Q, Ji XJ, Zhou YX, Yao XQ, Liu YQ,
Zhang F and Yin XX: Quercetin inhibits the mTORC1/p70S6K
signaling-mediated renal tubular epithelial-mesenchymal transition
and renal fibrosis in diabetic nephropathy. Pharmacol Res.
99:237–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ha H, Yang Y and Lee HB: Mechanisms of
reactive oxygen species generation in LLC-PKI cells cultured under
high glucose. J Am Sec Nephrol. 13:5312002.
|
|
32
|
Brosius FC, Khoury CC, Buller CL and Chen
S: Abnormalities in signaling pathways in diabetic nephropathy.
Expert Rev Endocrinol Metab. 5:51–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simonson MS: Phenotypic transitions and
fibrosis in diabetic nephropathy. Kidney Int. 71:846–854. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y: New insights into
epithelial-mesenchymal transition in kidney fibrosis. J Am Soc
Nephrol. 21:212–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, Liu
YX and Wang R: The role of the p38 MAPK signaling pathway in high
glucose-induced epithelial-mesenchymal transition of cultured human
renal tubular epithelial cells. PLoS One. 6:e228062011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu R, Wang Y, Xiao Y, Shi M, Zhang G and
Guo B: SnoN as a key regulator of the high glucose-induced
epithelial-mesenchymal transition in cells of the proximal tubule.
Kidney Blood Press Res. 35:517–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brownlee M: Biochemistry and molecular
cell biology of diabetic complications. Nature. 414:813–820. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Coughlan MT, Mibus AL and Forbes JM:
Oxidative stress and advanced glycation in diabetic nephropathy.
Annals of the New York Academy of Sciences. 1126:190–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang R, Ding G, Liang W, Chen C and Yang
H: Role of LOX-1 and ROS in oxidized low-density lipoprotein
induced epithelial-mesenchymal transition of NRK52E. Lipids Health
Dis. 9:1202010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang F, Hao Y, Zhang X and Qin J: Effect
of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads
signaling pathway in the db/db mice model of diabetic nephropathy.
Drug Des Devel Ther. 11:2813–2826. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Suwanabol PA, Seedial SM, Zhang F, Shi X,
Si Y, Liu B and Kent KC: TGF-β and Smad3 modulate PI3K/Akt
signaling pathway in vascular smooth muscle cells. Am J Physiol
Heart Circ Physiol. 302:H2211–H2219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen JK, Chen J, Neilson EG and Harris RC:
Role of mammalian target of rapamycin signaling in compensatory
renal hypertrophy. J Am Soc Nephrol. 16:1384–1391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee CH, Inoki K and Guan KL: mTOR pathway
as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol.
47:443–467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yeh YH, Wang SW, Yeh YC, Hsiao HF and Li
TK: Rhapontigenin inhibits TGF-β-mediated epithelial-mesenchymal
transition via the PI3K/AKT/mTOR pathway and is not associated with
HIF-1α degradation. Oncol Rep. 35:2887–2895. 2016. View Article : Google Scholar : PubMed/NCBI
|
